Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "genentech"

Genentech, BioNTech team up on cancer vaccines
BioPharma Dive

Genentech, BioNTech team up on cancer vaccines

Dive Brief: Privately-held BioNTech is teaming up with Roche's Genentech to develop, manufacture and commercialize messenger RNA (mRNA)-based cancer vaccines. Genentech will pay $310 million upfront in addition to near-term milestone payments. The ... BioPharma Dive, 3 days ago
Genentech, BioNTech to Partner on mRNA Cancer Vaccines Genetic Engineering News, 4 days ago

98 images for genentech

PRWeb, 5 days ago
BioPharma Dive, 3 days ago
Nasdaq, 3 days ago
Scrip Intelligence, 3 days ago
Business Insider, 2 weeks ago
San Francisco, 3 weeks ago
Globes, 2 weeks ago
Nasdaq, 3 weeks ago
Scrip Intelligence, 1 month ago
Mobihealthnews, 1 month ago
Renal & Urology News

Phase III Efficacy Results of Investigational Medicine Ocrevus (Ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis

-- Genentech, a member of the Roche group (SIX: RO, ROG; OTCQX: RHHBY), today announced new analyses from the three Ocrevus (ocrelizumab) Phase III studies in relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) will ...
 Drugs.com4 days ago ROCHE : MILITARY $36.34 Million Federal Contract Awarded to Genentech USA  4 Traders1 week ago Genentech Announces New Analyses From OCREVUS Phase III Studies In RMS  RTTNews.com1 week ago Ocrevus Demonstrates Positive Outcomes in RMS, PPMS Patients  Renal & Urology News1 week ago

BioLineRX, Genentech to collaborate on cancer drug

BL-8040 is a new category of cancer drug that is a robust mobilizer of immune cells and could be effective at inducing direct tumor cell death. Drug development company BiolineRX Ltd. (Nasdaq: BLRX ); TASE: BLRX ) today announced it had signed an ...
 Globes2 weeks ago Cancer Drug Developed by AbbVie and Genentech ???Melts Away Cancer???  BioSpace2 weeks ago ROCHE : BioLineRX, Genentech to collaborate on cancer drug  4 Traders2 weeks ago BIOLINERX : Announces In-licensing of Novel Treatment for Liver Failure Conditions Under Strategic Collaboration  4 Traders2 days ago

BioLineRx teams up with Genentech to evaluate combo of BL-8040 and Tecentriq in range of cancers

BioLineRx ( BLRX +7.6%) and Roche's ( OTCQX:RHHBY ) Genentech will collaborate in several Phase 1b clinical trials to evaluate the combination of BioLineRx's lead product candidate BL-8040 and TECENTRIQ (atezolizumab) in multiple cancers. Under ...
 Seeking Alpha2 weeks ago BioLineRx and Genentech to begin Phase Ib trials of drug combination for cancer indications  Drug Development Technology2 weeks ago

DNA Repair Drugs Report 2016-2026: PARP Inhibitors Focus - Analysis, Technologies & Forecasts - Key Vendors: 4SC, Genentech, Tesaro - Research and Markets

DUBLIN--(Business Wire)--Research and Markets has announced the addition of the "DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026" report to their offering. This comprehensive report is an elaborate study of drugs targeting DNA damage and ...
 Digital Journal2 weeks ago Immuno-Oncology Market by Product Type, 2016 - 2026  Digital Journal2 days ago Global Biorefinery Technologies Market Poised to Grow 8.4% - Industry Forecast to 2025 - Research and Markets  4 Traders2 days ago Orphan Drugs Market Report Predicts Healthy Growth by 2022 - Scalar Market Research  Digital Journal4 days ago

ArticleBioNTech set to earn $310 million near term under deal with Genentech21-09-2016

BioNTech has entered into a worldwide strategic collaboration with Genentech, to
 Pharma Letter4 days ago Genentech Gambles $310 Million+ on German Biotech BioNTech's mRNA Cancer Vaccine Tech  BioSpace4 days ago BioNTech to Enter Into Worldwide Strategic Collaboration With Genentech to Develop Individualized mRNA Cancer Therapies  BioSpace4 days ago Freshfields advises BioNTech on entering into worldwide strategic collaboration with Genentech to develop individualised mRNA cancer therapies  Legal Monitor3 days ago

ISPE Honors Genentech As 2016 Facility Of The Year

By Chemical Processing Staff Sep 21, 2016 The International Society for Pharmaceutical Engineering (ISPE) names Genentech as the Overall Winner of the 2016 Facility of the Year Awards (FOYA) program. The winner was revealed at ISPE's Annual ...
 Chemical Processing.com4 days ago ROCHE : ISPE Names 2016 Facility of the Year Awards Overall Winner  4 Traders5 days ago ISPE Names 2016 Facility of the Year Awards Overall Winner  MySanAntonio5 days ago

AC Immune prices IPO at $11, the low end of the range

AC Immune, a Swiss biotech developing therapies for Alzheimer's, partnered with Genentech, raised $66 million by offering 6 million shares at $11, the low end of the range of $11 to $13. AC Immune plans to list on the Nasdaq under the symbol ACIU.
 Nasdaq3 days ago Swiss biotech firm AC Immune increases IPO size  Sharenet2 days ago Swiss biotech AC Immune sells more shares in IPO  Yahoo! Finance2 days ago UPDATE 1-Swiss biotech firm AC Immune increases IPO size  Business Insider1 day ago

AC Immune IPO nets $58M for neurodegeneration R&D

AC Immune ($ACIU) has pulled off the potentially tricky task of persuading investors to back its IPO. The Genentech-partnered neurodegeneration specialist is offloading 6 million shares, 32% more than originally planned, at the bottom end of its ...
 FierceBiotech2 days ago Genentech-partnered AC Immune tees up $68M IPO to bankroll Alzheimer's R&D  FierceBiotech1 week ago AC Immune on deck for IPO  Seeking Alpha1 week ago AC Immune IPO Has Potential But Proceed With Caution  Seeking Alpha1 week ago

EuroBiotech Report: Genentech-BioNTech, $33M Series A, Alnylam, I/O and Prexton

Welcome to the latest edition of our weekly EuroBiotech Report. In a week in which the British biotech scene was peppered with upbeat news from companies, Germany's BioNTech trumped them all by unveiling a $310 million (€278 million) tie up with ...
 FierceBiotech3 days ago EuroBiotech Report: Alzheimer's gene therapy, IPOs, Innate Pharma and a 160% stock surge  FierceBiotech1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - genentech
Get updated on latest news & your favorite topics right in your inbox!
More     Less